These included inhibition of: (1) transcriptional activities of full-length AR and AR-V7; (2) transactivation of AR NTD; (3) protein–protein interactions; and (4) AR- and AR-V-dependent proliferation of prostate cancer cells. This evidence concerns the gene AR and prostate cancer.